CareFusion Corporation Pays Out $41 Million In ChloraPrep Settlement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CareFusion executes the $41 million settlement of a 2-year federal inquiry into marketing practices for its ChloraPrep skin preparation product. CareFusion (NYSE:CFN) said it closed out the $41 million settlement of a 2-year federal investigation into the marketing of its ChloraPrep antiseptic skin preparation wipes. The San Diego-based medical device company received a U.S. Justice Dept. subpoena in April 2011, seeking information related to its relationships with healthcare professionals.

Help employers find you! Check out all the jobs and post your resume.

Back to news